Nabsys Strengthens Leadership with Key Appointments
Recent strategic hires have bolstered Nabsys 2.0, LLC's ability to access broader markets and drive significant growth.
Exciting Developments in Commercial Leadership
Nabsys is pleased to announce the addition of Edd Lee as Global Vice President of Sales and Marketing. Edd brings extensive experience in the life sciences and healthcare sector, having successfully held senior roles at recognized companies such as Fabric Genomics, Pacific Biosciences, Illumina Inc., and Roche Diagnostics. His expertise will be instrumental as Nabsys seeks to expand its presence in the market.
Joining Edd is Bob Hertsenberg, who assumes the position of Global Head of Instrument Sales. Bob has a robust background in sales leadership from his tenure at Bionano Genomics. His experience managing commercial activities for genome mapping systems will be pivotal in driving Nabsys' direct and indirect sales channels for the OhmX Platform. Bob stated, "The OhmX Platform's innovative resolution and cost-effectiveness are set to revolutionize genome mapping. I am eager to connect more scientists with this transformative technology."
CEO and Founder Barrett Bready emphasized the value that both Edd and Bob bring. He said, "With their proven records in the genomics tools sector, we are excited to ramp up our efforts for the OhmX Platform. Their leadership will significantly contribute to our commercial success as we strive to enhance our market reach."
Additions to Operational Leadership
Richard H. Lussier has been appointed as Chief Operating Officer at Nabsys. He comes to the company with a wealth of experience in general management, sales, and research and development from various prominent positions. Richard previously served at The Jackson Laboratory, overseeing Clinical Genomics and spearheading product innovation and commercialization strategies. He has also held significant roles at Applied Biosystems Inc., Solexa Inc., Qiagen N.V., and Seven Bridges Genomics Inc.
Barrett Bready remarked, "The addition of Richard is incredibly timely as we seek to accelerate our growth. His leadership is expected to drive our mission to make electronic genome mapping a standard in genomic analysis worldwide."
About Nabsys
Nabsys, based in Providence, R.I., is committed to transforming genomic analysis through its innovative OhmX Analyzer. The company's multidisciplinary team is dedicated to enhancing the understanding of disease and improving patient outcomes by providing accurate and cost-effective genomic structural variation analysis.
Frequently Asked Questions
What recent leadership changes have occurred at Nabsys?
Nabsys recently appointed Edd Lee as Global VP of Sales and Marketing and Bob Hertsenberg as Global Head of Instrument Sales, alongside Richard H. Lussier as COO.
What is the OhmX Analyzer?
The OhmX Analyzer is a cutting-edge electronic genome mapping platform designed for high-resolution structural variant analysis in genomic studies.
How will the new appointments impact Nabsys's growth?
The new leaders bring extensive experience and networks that are expected to enhance the company's market reach and drive product adoption for the OhmX Platform.
Where is Nabsys located?
Nabsys is headquartered in Providence, Rhode Island, with a specialized team focused on genomic advancements.
What is Nabsys's mission?
The mission of Nabsys is to improve genomic understanding and patient outcomes through reliable and efficient genomic analysis.
